Meet Dr. Duke Bahn

Duke K. Bahn, M.D. Medical Director
Duke K. Bahn, M.D.

Internationally recognized as one of the world’s leading practitioners in the study and treatment of prostate cancer, Dr. Duke K. Bahn is currently the Director of the Prostate Institute of America at Community Memorial Hospital in Ventura California. His special areas of interest are the early detection and staging of prostate cancer using color-Doppler ultrasound with tissue harmonics. He is also a pioneer in using cryotherapy, as both a primary and salvage treatment for prostate cancer. Certified by the American Board of Radiology, Dr. Bahn spent more than twenty years in the research and development of cryoablation procedure for an effective prostate cancer treatment. His published data was the impetus for obtaining Medicare approval for cryotherapy as a viable primary treatment for prostate cancer.

Lately, he brought a concept of “Male Lumpectomy” in the prostate cancer treatment and standardizes the focal cryoablation technique that is freezing the cancerous portion of the prostate only as an outpatient, minimally invasive procedure. His latest task of cryoimmunotherapy clinical trial has FDA approval and being studied.

Dr. Bahn has held many academic and professional appointments including clinical professor of urology, Keck school of medicine, University of Southern California. He has published many scientific articles relating to the diagnosis and treatment of prostate cancer. He has been elected as “America’s Top Doctors” and “America’s Top Cancer Doctors”. He actively promotes prostate cancer education and patient empowerment through his extensive speaking appearances with both patient support groups and medical communities throughout the world.

PIOA Ongoing Clinical Trial

The Prostate Institute of America is performing an ongoing clinical trial for the treatment of advanced prostate cancer patients. Please review [&hellip